Envoy Medical terminates $15M ATM equity facility, cites capital confidence

Envoy Medical, Inc.

Terminated at-the-market equity facility effective June 24, 2026; originally authorized up to $15M in common stock sales.
Company says termination reflects confidence in current capital position; no immediate need for equity financing.
ATM Agreement was dated January 17, 2025; termination is voluntary and not due to any default.
No other material agreements or changes reported in the filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.